logo

For the Inventor, By the Inventor

Basking Ridge, NJ, United States of America

John E Francis

USPTO Granted Patents = 10

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 98(Granted Patents)


Location History:

  • Pleasantville, NY (US) (1978 - 1982)
  • Briarcliff Manor, NY (US) (1978 - 1990)
  • Basking Ridge, NJ (US) (1987 - 1993)

Company Filing History:

goldMedal10 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1978-1993

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5180718 - Acyl derivatives of oxazolorifamycins (1993-01-19),
2. 5034381 - 2-(substituted amino) adenosines as antihypertensives (1991-07-23),
3. 4977144 - Imidazo[4,5-b]pyridine derivatives as cardiovascular agents (1990-12-11),
4. 4912125 - 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles for reducing (1990-03-27),
5. 4908376 - 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles in composition form for (1990-03-13),
6. 4831013 - 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical (1989-05-16),
7. 4713383 - Triazoloquinazoline compounds, and their methods of preparation, (1987-12-15),
8. 4329367 - 1-(Aralkoxyphenyl)-2-(bis-arylalkylamino)-alkanes (1982-05-11),
9. 4110457 - Bis-arylalkylamino-aralkanes (1978-08-29),
10. 4091103 - Quinolyl or isoquinolyl-lower-alkoxy-phenylene-amino derivatives (1978-05-23),

Title: The Innovative Contributions of John E. Francis

Introduction

John E. Francis is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on developing novel compounds that can be utilized in medicaments.

Latest Patents

Among his latest patents, one includes the invention of acyl derivatives of oxazolorifamycins. This invention relates to novel acyl derivatives of rifamycins, which can be used as active compounds in medicaments. Another significant patent involves 2-(substituted amino) adenosines as antihypertensives. This patent discloses adenosine derivatives that serve as therapeutically effective adenosine-2 (A-2) agonists.

Career Highlights

John E. Francis has had a distinguished career at Ciba-Geigy Corporation, where he has been instrumental in advancing pharmaceutical research. His innovative work has led to the development of compounds that have the potential to improve health outcomes for patients.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Alan J. Hutchison and Charles F. Huebner. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

John E. Francis exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents have the potential to make a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…